Article
Pharmacogenomics of the human µ-opioid receptor.
Pharmacogenomics - 1 Sept 2011
Kasai Shinya, Ikeda Kazutaka
Abstract excerpt
The µ-opioid receptor is a primary target for clinically important opioid analgesics, including morphine, fentanyl and methadone. Many genetic variations have been identified in the human µ-opioid receptor MOP gene (OPRM1), and their implications have been reported in the effects of opioid drugs and susceptibility to drug dependence. Interestingly, agonistic and antagonistic opioid effects are inversely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
